Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000462556 | SCV000544458 | pathogenic | Tuberous sclerosis 2 | 2016-08-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal at codon 324 (p.Tyr324*) of the TSC2 gene. It is expected to result in an absent or disrupted protein product. Truncating variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). While this particular variant has not been reported in the literature, a different nucleotide change (c.972C>G) with the same effect on the TSC2 protein (p.Tyr324*) was identified in a patient affected with tuberous sclerosis complex (TSC) (PMID: 10735580). For these reasons, this variant has been classified as Pathogenic. |
Tuberous sclerosis database |
RCV000043213 | SCV000067014 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |